Biomarkers that could be targets for novel drugs to treat glioblastoma brain tumors have been identified, providing hope for a cancer that is highly lethal. This new finding provides early evidence that there may be a benefit in targeting specific alterations in cancer cells with newer agents once a patient’s tumor becomes resistant to temozolomide.
Click here for original story, Biomarkers found that could be drug targets against a deadly form of brain cancer
Source: ScienceDaily